INO Competitors
Inovio Pharmaceuticals, Inc.
$1.51
+$0.29(+24.28%)
53
Overall
60
Value
66
Tech
34
Quality
Market Cap
$156.13M
Volume
31.14M
52W Range
$0.56 - $2.72
Target Price
$5.33
INO competitors: PFE, JNJ, ARWR, NVS, MRK. Inovio Pharmaceuticals, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
INO Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| PFE Pfizer Inc. | $29.23 | $167.52B | $3.04 | 4.41% | 74 |
| JNJ Johnson & Johnson | $282.11 | $664.95B | $11.12 | 1.87% | 70 |
| ARWR Arrowhead Pharmaceuticals, Inc. | $49.24 | $8.22B | $-3.62 | - | 30 |
| NVS Novartis AG | $163.69 | $310.17B | $9.04 | 2.92% | 68 |
| MRK Merck & Co., Inc. | $148.76 | $361.73B | $2.78 | 2.29% | 69 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INO | $1.51 | +24.3% | 31.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Inovio Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW